Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G/A for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 3.6%.
- Date of event: 31 Mar 2025.
AdvisorShares Trust - 31 Mar 2025 SCHEDULE 13G/A Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- ENVB
- Shares outstanding
- 2,474,630 shares
- Disclosed Ownership
- 90,324 shares
- Ownership
- 3.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 Apr 2025, 16:12:57 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 06 Jan 2025
- Next filing
- 03 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 3.6% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 06 Jan 2025.
- Current filing was accepted on 02 Apr 2025, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 3.6% | 90,324 | 90,324 | 0 | /s/ Stefanie Lititle | Stefanie Little - Chief Compliance Officer |